Beyond simple diagnostics,theranostics is intended to give clinicians the possibility to implement a treatment customized for each patient, while controlling the efficacy of the treatment by anticipating therapeutic escape and other secondary effects inherent in these biotherapies.
BMD offers Theradiag’s innovative line of products with high medical value. The LISA TRACKER kits are the first CE marked kits allowing clinicians to monitor the patient’s trough plasma levels of three parameters over time.
Prescribed drug (original biological or biosimilar) to optimize dosage consistent with the presence or absence of ADAb.
The presence of anti-drug antibodies (ADAb), of which authors have reported the presence among patients experiencing loss of drug efficacy.
Circulating TNFα is one of the main markers involved in the inflammatory process. TNFα is a complex predictive marker that may lead to new areas of research.
The combination of these three parameters allows to anticipate, optimize, and better manage the patients’ treatment.